# Rocket Pharmaceuticals, Inc.: Form 8-K, filed Jul 23, 2025

- Company: [Rocket Pharmaceuticals, Inc.](/companies/rckt.md) (CIK 1281895)
- Form: 8-K
- Filed: 2025-07-23
- Accepted by EDGAR: Jul 23, 2025, 16:29 ET
- Period: 2025-07-23
- Accession: 0001140361-25-026946
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1281895/000114036125026946/ef20052517_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1281895/000114036125026946/

## Items reported

- Item 2.05: Exit or disposal costs

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1281895/000114036125026946/ef20052517_8k.htm

Filed Jul 23, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-026946. Last ingested by Listed: Nov 10, 2026, 01:55 ET. No prices; not investment advice.